Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vuk Zdinjak

Cara Therapeutics To Host Virtual R&D On March 11

Cara Therapeutics, (NASDAQ:CARA) known for its research on cannabinoid receptor agonists for the relief of inflammatory and neuropathic pain, will host a virtual research and development event on Friday, March 11 from 1:00 to 2:00 p.m. ET. The presentation will focus on the initiation of oral difelikefalin Phase 3 programs for the treatment of pruritus in patients with atopic dermatitis and non-dialysis dependent chronic kidney disease.

An interactive Q&A session will follow the presentation.

Presenters will include:

Christopher Posner, president & CEO and director of Cara Therapeutics

  • Joana Goncalves, MD, chief medical officer of Cara Therapeutics
  • Brian Kim, MD, MTR,
  • Jonathan Silverberg, MD, Ph.D., MPH

 

 

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.